AVP and septic shock: The major finding of the present study is that in fluid-resuscitated septic shock patients treated with NE to maintain a MAP between 65 and 75 mmHg, the addition of continuously infused low-dose TP and AVP does not affect sublingual microcirculatory blood flow compared with placebo.